Status:
COMPLETED
Comparison of the Combination of Fenofibrate and Simvastatin Versus Pravastatin
Lead Sponsor:
Solvay Pharmaceuticals
Conditions:
Hyperlipidemia
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
Mixed or combined hyperlipidemia is a common metabolic disorder characterized by both hypercholesterolemia and hypertriglyceridemia. Statins and fibrates have complementary mechanisms and can be coadm...
Eligibility Criteria
Inclusion
- Mixed dyslipidemia
Exclusion
- Known hypersensitivity to fenofibrates or simvastatin or pravastatin
- Pregnant or lactating women
- Contra-indication to fenofibrate or simvastatin or pravastatin
- Unstable or severe cardiac disease
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2008
Estimated Enrollment :
423 Patients enrolled
Trial Details
Trial ID
NCT00362206
Start Date
September 1 2006
End Date
September 1 2008
Last Update
July 8 2009
Active Locations (41)
Enter a location and click search to find clinical trials sorted by distance.
1
Site 40
Athens, Greece
2
Site 39
Ioannina, Greece
3
Site 41
Thessaloniki, Greece
4
Site 37
Beer Yaakov, Israel